| Michael Thomas Fabian, PMHNP | |
|
1501 Hughes Way Ste 150, Long Beach, CA 90810-1878 | |
| (310) 221-6336 | |
| (916) 703-6547 |
| Full Name | Michael Thomas Fabian |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 1501 Hughes Way Ste 150, Long Beach, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003364514 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 95008567 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Thomas Fabian, PMHNP 1501 Hughes Way Ste 150, Long Beach, CA 90810-1878 Ph: (310) 221-6336 | Michael Thomas Fabian, PMHNP 1501 Hughes Way Ste 150, Long Beach, CA 90810-1878 Ph: (310) 221-6336 |
News Archive
While obesity is a complex and multifaceted problem, much of the strategy behind combating it boils down to healthy eating habits. Taking into account the primary role of subjective appetite sensations in said habits, a group of researchers recently compared the satiety impact of two popular breakfast choices: oatmeal and ready-to-eat breakfast cereal (RTEC).
GE Healthcare, a unit of General Electric Company, today announced the installation of Russia's first high-definition computed tomography (CT) scanner, GE Healthcare's flagship Discovery CT750HD, at the Center of Medical Rehabilitation by the Russian Ministry of Health in Moscow led by Professor Konstantin V. Lyadov.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
Research from McGill University reveals that the brain's motor network helps people remember and recognize music that they have performed in the past better than music they have only heard.
Opexa Therapeutics, Inc., a leading cell therapy company developing Tovaxin for multiple sclerosis, today announced the successful completion of two separate meetings with the U.S. Food and Drug Administration regarding the Company's planned development program for Tovaxin.
› Verified 4 days ago
Mrs. Elisha Marie Martin, MSN, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2801 Atlantic Ave, Long Beach, CA 90806 Phone: 310-350-8902 | |
Ms. Eunice N Bisong, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1501 Hughes Way Ste 150, Long Beach, CA 90810 Phone: 310-221-6336 | |
Mia Spinelli Loftus, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 701 E 28th St Ste 419, Long Beach, CA 90806 Phone: 562-490-9900 | |
Christine Marie Moak, AGACNP-BC Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 3060 Mcnab Ave, Long Beach, CA 90808 Phone: 562-277-4741 | |
Mrs. Christine Uy Titensky, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 701 E 28th St Ste 301, Long Beach, CA 90806 Phone: 562-269-0300 | |
Mr. Alvaro Gonzales Botello, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1045 Atlantic Ave Suite 715, Long Beach, CA 90813 Phone: 562-983-5496 Fax: 562-432-1864 |